Xu Yan
- Cancer Research top 5%
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 5
- Neurology top 5%
- Neurological diseases and metabolism 3
-
- Plasma Applications and Diagnostics 12
- Molecular Biology top 10%
- Heme Oxygenase-1 and Carbon Monoxide 6
- Mitochondrial Function and Pathology 3
- Pharmacology top 5%
-
- Electrohydrodynamics and Fluid Dynamics 5
-
- Neuroscience and Neuropharmacology Research 4
- Co-authors
- Guangyuan HeGuangxiao YangZilan XiongKostya OstrikovXinpei LuFei ZouBisheng ZhouWenxia Si
- Journals
- Journal of Biological Chemistry (1 paper)SHILAP Revista de lepidopterología (1 paper)Applied Physics Letters (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xu Yan
60 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 122
- Cancer Research 309
- Neurology 135
- Radiology, Nuclear Medicine and Imaging 363
- Molecular Biology 885
- Pharmacology 81
Countries citing papers authored by Xu Yan
This map shows the geographic impact of Xu Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Yan more than expected).
Fields of papers citing papers by Xu Yan
This network shows the impact of papers produced by Xu Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Yan. The network helps show where Xu Yan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xu Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 5 | |
| 5 | 2021 | 8 | |
| 6 | 2020 | 35 | |
| 7 | 2020 | 6 | |
| 8 | 2019 | 5 | |
| 9 | 2019 | 21 | |
| 10 | 2018 | 19 | |
| 11 | 2018 | 12 | |
| 12 | 2017 | 21 | |
| 13 | 2014 | 38 | |
| 14 | 2014 | 32 | |
| 15 | 2014 | 28 | |
| 16 | 2014 | 45 | |
| 17 | 2014 | 39 | |
| 18 | 2012 | 82 | |
| 19 | 2009 | 1 | |
| 20 | 2009 | 86 |
About Xu Yan
Xu Yan is a scholar working on Neurology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 60 papers that have together received 1.6k indexed citations. Recurring topics across this work include Plasma Applications and Diagnostics (12 papers), MicroRNA in disease regulation (10 papers), Heme Oxygenase-1 and Carbon Monoxide (6 papers), Electrohydrodynamics and Fluid Dynamics (5 papers), Cancer-related molecular mechanisms research (5 papers), Neuroscience and Neuropharmacology Research (4 papers), Neurological diseases and metabolism (3 papers) and Mitochondrial Function and Pathology (3 papers). The work is most often cited by research in Cancer Research (309 citations), Neurology (135 citations) and Radiology, Nuclear Medicine and Imaging (363 citations). Xu Yan has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Guangyuan He, Guangxiao Yang, Zilan Xiong, Kostya Ostrikov, Xinpei Lu, Fei Zou, Bisheng Zhou, Wenxia Si, Xin Tu and Cecilia A. Brunello. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Applied Physics Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.